To Evaluate the Safety and Pharmacokinetic Characteristics After the Administration of JT-001, JT-002 and JLP-2008
Conditions: Healthy Adult Interventions: Drug: SGLT2 inhibitor Sponsors: Jeil Pharmaceutical Co., Ltd. Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Research | SGLT2 Inhibitors